On The Pen With Dave Knapp Podcast By Dave Knapp Man On The Mounjaro Bleav cover art

On The Pen With Dave Knapp

On The Pen With Dave Knapp

By: Dave Knapp Man On The Mounjaro Bleav
Listen for free

About this listen

 Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!© 2025 On The Pen With Dave Knapp Hygiene & Healthy Living Physical Illness & Disease Politics & Government
Episodes
  • Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?

    Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?
    May 20 2025

    Join the Substack here: onthepen.substack.com
    Get all my links here: https://linktr.ee/manonthemounjaro
    Show more Show less
    30 mins
  • Zepbound vs. Wegovy, CVS vs. Patients, and the Executive Order That Changes Everything

    Zepbound vs. Wegovy, CVS vs. Patients, and the Executive Order That Changes Everything
    May 13 2025

    Joe's Petition + All My Links:
    https://linktr.ee/manonthemounjaro
    Show more Show less
    41 mins
  • Compound Tirzepatide Lawsuit + PBM Reform Update // OTP TWD 5.6.25

    Compound Tirzepatide Lawsuit + PBM Reform Update // OTP TWD 5.6.25
    May 6 2025

    Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine.

    Find our substack and all promotional links here:
    https://linktr.ee/manonthemounjaro
    Show more Show less
    27 mins
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
All stars
Most relevant  
This is my go to info on how to handle dr’s, updated meds info, compounding, and how to talk about obesity as a disease. Love it!

Great for all the latest updates

Something went wrong. Please try again in a few minutes.